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Abstract 
The incidence of pre-lingual hearing loss (HL) is about 1 in 1000 neonates. More 
than 60% of cases are inherited. Non-syndromic HL (NSHL) is extremely 
heterogeneous: more than 130 loci have been identified so far. The most common 
form of NSHL is the autosomal recessive form (ARNSHL). In this study, a cohort of 
36 big ARNSHL pedigrees with 4 or more patients from 7 provinces of Iran was 
investigated. All of the families were examined for the presence of GJB2 and GJB6 
(del D13S1830 and del D13S1854) mutations using direct sequencing and multiplex 
PCR methods, respectively. The negative pedigrees for the above-named genes were 
then tested for the linkage to 5 known loci including DFNB3 (MYO7A), DFNB4 
(SLC26A4), DFNB7/11 (TMC1), DFNB21 (TECTA) and DFNB59 (PJVK) by 
genotyping the corresponding STR markers using PCR and PAGE. Six families had 
GJB2 mutations. No GJB6 mutation was found. Totally, 3 families showed linkage to 
DFNB4, 1 family to DFNB7/11 and 1 family to DFNB21. No family was linked to 
DFNB59. GJB2 included 16.6% of the causes of ARNSHL in our study. In the 
remaining negative families, DFNB4 accounted for 10% of the causes. Other loci 
including DFNB7/11 and DFNB21 were each responsible for 3.3% of the etiology. 
Thus, DFNB1(GJB2) and DFNB4 are the main causes of ARNSHL in our study and 
GJB6 mutations (del D13S1830, del D13S1854), DFNB3 and DFNB59 were absent. 
Totally, 30.5% of the ARNSHL etiology was found in this study. 
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Introduction 
Hearing loss (HL) is the most common sensory 
disorder in human. One per thousand neonates are with 
pre-lingual HL. Also, some degrees of HL negatively 
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the age of 45 and 10% of people at the age of 65 and 
older [1-3]. HL has a wide spectrum of clinical 
manifestations including: congenital or late-onset, 
conductive or neurosensory and syndromic or non-
syndromic. Based on the severity, it is also classified as 
mild, moderate, severe and profound. Over 60% of HL 
is inherited. As the sanitary quality index improves, the 
contribution proportion of genetic to non-genetic factors 
increases [2]. Approximately, 80% of HL cases are non-
syndromic (NSHL) with the autosomal recessive mode 
of inheritance (ARNSHL) making up the majority of 
cases. The phenotype is normally pre-lingual and more 
severe in these cases [1-3]. Up to 1% of human genes 
are estimated to be involved in hearing process and over 
130 loci have been identified so far for NSHL. Thus, 
HL is the most heterogeneous human trait known [4,5]. 
For ARNSHL alone, over 70 loci have been identified 
[6]. 
Iran, with a high consanguinity marriage rate and 
with a heterogeneous population, offers a good 
opportunity to study rare autosomal recessive disorders 
including ARNSHL. Most studies on ARNSHL have 
only addressed certain loci with a special focus on CX26 
(GJB2), the most common cause of ARNSHL. Studies 
on the main loci involved in the Iranian ARNSHL 
patients seem to be essential in order to clarify their 
roles. The results of such studies could be applied to a 
more efficient genetic screening of the disease and the 
concomitant genetic counseling. The present research 
was launched to determine the contribution of several 
genetic factors to the studied ARNSHL series. Starting 
with the screening of the ARNSHL families with more 
prevalent genes including GJB2(MIM# 121011) and 
GJB6 (CX30) (MIM# 604418) (del D13S1830 and del 
D13S1854), the study continued to the next step by the 
genetic linkage analysis for 5 known DFNB loci, 
including DFNB3 (MYO7A), DFNB4 (SLC26A4), 
DFNB7/11 (TMC1), DFNB21 (TECTA) and DFNB59 
(PJVK) in the families negative for mutations in the two 
genes. 
Materials and Methods 
Sampling and DNA Extraction 
The study was approved by the Institutional Review 
Boards of Tehran University of Medical Sciences and 
Shahrekord University of Medical Sciences. In this 
descriptive study, 36 families with 4 or more cases were 
collected form 7 provinces of Iran, including Charmahal 
va Bakhtiari, Fars, Guilan, Tehran, Khuzestan, 
Azarbaijan Sharghi and Kurdestan. A pre-designed 
questionnaire separately filled out for each family 
together with clinical evaluations helped exclude non-
syndromic forms of HI. Informed consent was taken 
from all the family members, 5-10  ml of whole blood 
was collected in 0.5 M EDTA containing  tubes. 
Genomic DNA was extracted by a standard phenol-
chloroform method. DNA concentration and purity was 
measured by spectroscopy (UNICO 2100, USA) [6,7]. 
Screening of GJB2 by Direct PCR-Sequencing 
One patient was sequenced from each part of the 
pedigrees. Following primers were designed using 
Primer 3 web-based software: F: 5'-CTCCCTGTTCTG 
TCCTAGCT-3' R: 5'-CTCATCCCTCTCATGCTGTC-
3'. A single PCR product of 809 bp was obtained using 
the following conditions for each reaction: 2 µl MgCl2 
(50 mM), 2.5 µl Taq PCR buffer (10X), 1µl of each of 
the primers (10 PM), 0.1 µl Taq DNA polymerase 
(5U/ul), 1 µl dNTP mix (10 mM) and 1µl DNA (about 
50 ng). The reaction was adjusted to the volume of 25ul 
by ddH2O. Standard cycling conditions was performed 
in a thermocycler (ASTEC PC818-Japan) as follows: 
95°C for 3 min; 35 cycles of 94°C for 30'', 57°C for 45'', 
72°C for 45'', and a final extension at 72°C for 7 min. 
PCR product was run in a 6-8% polyacrylamide gel 
electrophoresis (PAGE) (Merk, Germany) at 40 mA for 
2 h. Bands were visualized by silver staining [9]. 
Subsequently, DNA sequencing of the PCR-amplified 
product was carried out bi-directionally on an ABI 3130 
automated sequencer (Applied Biosystems) (Macrogen, 
South Korea) using the same primers. 
Screening of GJB6 Deletions 
A multiplex PCR assay was performed to detect del 
(GJB6-D13S1830) and del (GJB6-D13S1854) using 
following primers:  
F1: 5’-CACCATGCGTAGCCTTAACCATTTT-3’ 
R1: 5’-TTTAGGGCATGATTGGGGTGATTT-3’ 





(for amplification of the del (GJB6-D13S1854) 
breakpoint junction); 
GJB6 (exon 1): 
F3: 5’-CATGAAGAGGGCGTACAAGTTAGAA-3’ 
R3: 5’-CGTCTTTGGGGGTGTTGCTT-3’ 
(for amplification of GJB6 exon 1). 
The logic behind the multiplex PCR is that by any of 
the deletions the breakpoint junctions will amplify: 
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amplicons of 460 bp and 564 bp, respectively. 
While, the segment containing GJB6 exon 1 (F3R3)  
will be lost in homozygous state. In the wild type, we 
should only have F3R3 amplicon (333bp) [8]. Each 
reaction contained: 1 MgCl2 (50 mM), 2.5 µl Taq PCR 
buffer (10X), 0.5 µl of each of the primers (10 PM), 0.1 
µl Taq DNA polymerase (5U/ul), 0.5 µl dNTP mix (10 
mM) and 1µl DNA (about 50 ng). The total volume was 
adjusted to 25 µl by ddH2O. A touch down thermal 
program was performed as follows: One cycle of 
denaturation at 95°C for 3 minutes; five touchdown 
cycles of denaturation at 94°C for 40'', annealing at 
64°C for 40'' in the first cycle with 1°C reduction per 
cycle, and extension at 72°C for 45''; 27 cycles of 
denaturation at 94°C for 45'', annealing at 60°C for 40'', 
and extension at 72°C for 45''; and a final extension step 
of 72°C for seven minutes. PCR products were resolved 
by 6-8% PAGE. A positive control, heterozygous for 
del(GJB6-D13S1830), was used.  
Genotyping STR Markers, SLINK and Linkage 
Analysis 
Short tandem repeat (STR) markers were amplified 
by PCR. The following general protocol was carried out 
with some modifications for some STR markers. Each 
reaction contained: 3 MgCl2 (50 mM), 2.5 µl Taq PCR 
buffer (10X), 1 µl of each of the primers (10 PM), 0.1 µl 
Taq DNA polymerase (5U/ul), 1 µl dNTP mix (10 mM) 
and 1µl DNA (about 50 ng). The total volume was 
adjusted to 25 µl by ddH2O.  
A touch down thermal cycling was programmed as 
follows: One cycle of denaturation at 95°C for 3 
minutes; six touchdown cycles of denaturation at 94°C 
for 45'', annealing at 59°C for 45'' in the first cycle with 
1°C reduction per cycle, and extension for 45'' at 72°C; 
30-33 cycles of denaturation at 94°C for 45'', annealing 
at 54°C for 45'', and extension for at 72°C for 45''; and a 
final extension step of 72°C for seven minutes. PCR 
products were run on 8-12% PAGE at 50 mA for 3-6 h.  
Silver staining was followed and bands were 
visualized [9]. Alleles were assigned by visual 
inspection. At least, two screening markers were 
analyzed for every known locus. The selection of STR 
markers was based on their physical distance found at 
NCBI UniSTS and NCBI Map Viewer. Upon 
encountering an uninformative marker, further markers 
were examined. The primer sequences are available 
upon request. 
SLINK analysis was performed by FastSlink version 
2.51. Two-point and multi-point parametric LOD scores 
were calculated by Superlink version 1.6  and Simwalk 
version 2.91 options of Easylinkage plus version 5.05 
software [11]. After linkage analyses, haplotypes were 
reconstructed via Simwalk and were visualized by 
Haplopainter software version 029.5 [9]. 
Results 
Screening of GJB2 and GJB6 Genes 
Out of the 36 studied pedigrees, 6 pedigrees were 
found to have GJB2 mutations. In the remaining 30 
pedigrees, GJB6 deletions were investigated. No 
deletions of GJB6 were found and all the individuals 
showed the normal 333 bp band (Fig. 1). 
Genotyping STR Markers, SLINK and Linkage 
Analysis 
We initially analyzed a part of a pedigree, that 
included one consanguinity loop comprising parents, 
two non-affected and two affected individuals, by at 
least two informative microsatellite markers. In case, all 
the patients were homozygous (i.e. showing one single 
band), hence, different from the pattern seen for the 
non-affected individuals, including carriers and non-
carriers, all parts of the pedigree would be analyzed for 
confirmation of the linkage and more informative 
markers were genotyped. Priority of screening was with 
intragenic markers. A sample of linked genotype is 
shown in Figure 2. 
Thirty families that were negative  for GJB2 and 
GJB6 gene mutations were analyzed by the genetic 
linkage analysis for 5 DFNB loci including DFNB3, 
DFNB4, DFNB7/11, DFNB21 and DFNB59. Three 
families showed linkage to DFNB4. We found also one 
family linked to DFNB7/11 and one family linked to 
DFNB21. No family was linked to DFNB3 or DFNB59. 
We used D17S921, D17S953, D17S2196 and 
D17S2206 as the screening markers of DFNB3 and 
D2S2981 , D2S2173, D2S 324, D2S 2314 as the 
screening markers of DFNB59 in this study. 
 
Table 1. Calculated SLINK and LOD score (two-point and 
multi-point) values for the linked families. SLINK value 
theoretically estimates the LOD score for a given family 







IR-GHA DFNB7/11 1.8 1.6 2.0 
IR-JOL DFNB4 2.4 2.1 2.4 
IR-SH9 DFNB4 6.2 3.5 5.1 
IR-ABY DFNB4 7.4 3.4 4.6 
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The haplotypes of the linked families are shown in 
Figure 3 (a-e). SLINK and LOD score values (two- 
point and multi-point) are illustrated for the linked 
families (Table 1). As evident, the LOD score values 
match to some extent with SLINK values. SLINK 
would predict a theoretical  estimation for LOD score in 
a given family. For LOD score calculations, equal 
recombination for both sexes, autosomal recessive 
pattern of inheritance, with complete penetrance and no 
phenocopy, and disease allele frequency of 0.001 were 
assumed. 
Discussion 
In this study, we analyzed 36 ARNSHL families 
from 7 provinces of Iran including Charmahal va 
Bakhtiari, Fars, Guilan, Tehran, Khuzestan, Azarbayjan 
Sharghi and Kurdestan. After screening GJB2 mutations 
and two GJB6 deletions including D13S1830 and 
D13S1854, the genetic linkage and haplotype analysis 
was carried out by STR markers for the 5 studied DFNB 
loci. Since GJB2 mutations account for 18.29% of 
ARNSHL and 12.7% of sporadic cases, and for the 
extreme heterogeneity of the disease and population 
diversity of Iran, studying other loci seems to be 
essential and is expected to provide us with an insight 
into the roles of other loci in pathogenesis of ARNSHL 
in Iran [15]. 
In the present study, 6 families were homozygous to 
GJB2 gene which were set aside for the rest of the 
study. This fits well with the 16.6% [16] or 18.29% [15] 
rate of GJB2 involvement in ARNSHL. This also 
emphasizes the heterogeneity of the Iranian population 
and puts forth the fact that other loci as well as novel 
ones may be involved. DFNB1 is the first locus to be 
identified and is the most common locus in ARNSHL. 
Its rate of involvement (0-50%) is partly population-
dependent and has been estimated to account for up to 
50% of ARNSHL cases in the North American, 
Mediterranean and most of the European populations 
[10-12]. 
GJB6 lies adjacent to GJB2, that causes HL, in 
DFNB1 locus. Its two common deletions include 
del(GJB6-D13S1830) and del(GJB6-D13S1854). The 
former deletion is 309 Kb and causes HL in such 
countries as Spain, France, UK, Brazil, USA, Belgium 
and Australia either in homozygous status or as 
compound heterozygous with other GJB2 mutations 
[13-15]. In one study, the prevalence of the deletion was 
found to be between 5.9 to 9.7% of all the DFNB1 
alleles in the populations of Spain, France, UK and 
Brazil [18]. Therefore, it was nominated as the second 
mutant allele after 35delG, the single most frequent 
GJB2 mutation in some studied populations. Notably, 
10-50% of HL individuals having GJB2 mutation are 
heterozygous and del(GJB6-D13S1830) is the second 
mutant allele in 30 to 70% of these cases [14] However, 
it must be noted that the deletion has no role in 
pathogenesis of HL in a variety of European and Asian 
populations including Austria, Croatia, China and India 
[16-20]. 
del(GJB6-D13S1854) is a 232 Kb deletion which has 
been found more recently in GJB6 in the same region of 
the other deletion. This deletes a shorter region 
upstream of GJB2 as compared to del(GJB6-D13S1830) 
[19]. The distribution of the two deletions is different in 
various populations. In fact, del(GJB6-D13S1830) is 
much  more prevalent and has been reported from 
various countries. In contrast, del(GJB6-D13S1854) has 
been reported from a limited number of families [8]. 
Both mutations have been reported from Spain and UK 
in 10.6% and 9.8% of mutant DFNB1 alleles, 
respectively, and are listed among the five more 
frequent DFNB1 mutations. Interestingly, unlike the  
 
 
Figure 1. Analysis of two common GJB6 deltions in 
ARNSHL families. Column order is as follows: 1: marker, 2-
4: patients, 5: negative control (all PCR reaction materials 
except DNA), 6: positive control (a heterozygous del(GJB6-




Figure 2. Gnotyping STR markers using Polyacrylamide gel 
electrophoresis (PAGE) 12% for a DFNB4 marker in a 
DFNB4 linked family is shown. Column order is as follows: 1: 
marker, 2: father, 3: mother 4-6: affected siblings 7: a non-
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high prevalence of del(GJB6-D13S1830) in France, 
there has been no report of del(GJB6-D13S1854). In 
Belgium, del(GJB6-D13S1830) is not a prevalent allele 
and thus far, del(GJB6-D13S1854) has not been 
reported [18]. Previous studies in Iran have not detected 
del(GJB6-D13S1830) in populations from the Western, 
North-Eastern and Central Iran [21-23]. This is in 
agreement with our results and suggests that it may have 
no role in pathogenesis of ARNSHL in our country. 
Neither did we find any positive case for del(GJB6-
D13S1854). This is the first  evidence to address the 
deletion in Iran and suggests that it may not contribute 
to ARNSHL in Iran. 
Out of the 30 remaining families negative for GJB2 
and GJB6 mutations, 3 families (10%) were linked to 
DFNB4. The locus contains SLC26A4 gene. In a study 
aimed at identifying the causes of HL in the South Asia, 
212 Pakistani and 106 Indian families with 3 or more 
HL patients were investigated. About 5% of ARNSHL 
cases in South Asia as well as other populations were 
suggested to be caused by SLC26A4 mutations [24,25]. 
DFNB4 accounts for both syndromic and non-
syndromic forms of HL. In a study, out of 80 Iranian 
families with 2 or more HL patients, 12 families (15%) 
were linked to DFNB4 locus with clues for 5 families to 
be syndromic [26]. In a recent study, out of 34 families 
negative for GJB2, 3 families (8.8%) were linked to 
DFNB4. Thus, DFNB4 contributes significantly to HL 
in Iran and is ranked 2nd After DFNB1 [27]. 
In our study, one family (3.3%) was linked to 
DFNB7/11. Linkage to the locus has been obtained in 
10 families out of 230 consanguineous families from 
India and Pakistan and a novel gene called TMC1 was 
found [31]. TMC1 mutations seem to be a rather 
common cause of ARNSHL in India and Pakistan. 
Mutations of the gene have also been found in Turky 
[31]. In a research in the North East and East of Turky, 
using homozygosity genome scan analysis, 4 out of 65  
 
Figure 3. Haplotypes of families linked to DFNB7/11 (a), 
DFNB4 (b-d), DFNB21 (e). Patients are shown in black. a) 
Family IR-GHA linked to DFNB7/11. Markers D9S1837, 
D9S1124 and D9S1876 are intragenic.The order of markers is 
based on the Marshfiled map. b) In IR-ABY a cross-over in 
one of the upper generations of individual 4 between markers 
D7S2459 (which is an intragenic marker) and D7S2456, has 
created two haplotypes segregating with HL in two parts of 
the pedigree. c) Family IR-SH9 linked to DFNB4. Marker 
D7S2459 is intragenic.The order of markers is based on the 
Marshfiled map. d) Family IR-JOL linked to DFNB4. Marker 
D7S2459 is intragenic. The order of markers is based on the 
Marshfiled map. e) Family IR-JAF linked to DFNB21. Marker 
D11S4089 and D11S4107 are intragenic. The order of markers 
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(6.15%) families, negative for GJB2, were shown to be 
linked to DFNB7/11 [28]. In one study, out of 32 
ARNSHL families with 2 or more patients and from 
different parts of Iran, 3 families (9.4%) showed linkage 
to DFNB7/11. It was concluded that the locus could be 
one of the most common causes of ARNSHL in the 
Iranian population [33]. 
No linked family was found for DFNB3 in our study. 
DFNB3 contains MYO15. In a study on consanguineous 
families of Pakistan, 10% were linked to DFNB3 (11 
out of 112). Thus, it was suggested that at least 5% of 
the studied Pakistani ARNSHL population were caused 
by the gene [34]. In a study on 40 Iranian families from 
Qom and Markazi provinces of Iran with 3 or more 
ARNSHL, 2 families were linked to DFNB3 (5.8%) 
[27]. It is likely that a more frequent involvement of 
DFNB3 exists in some populations of Iran comparing to 
the others. More ARNSHL families have to be studied 
before reaching any definite conclusion on the issue. 
We found one family linked to DFNB21 in this 
study. The corresponding gene, TECTA, can cause both 
dominant and recessive HL. The first report of 
ARNSHL family caused by the locus was on a large 
Lebanese family [29]. In a study, linkage to DFNB21 
was found in 3 (6.6%) out of 45 Iranian consanguineous 
families which were negative for GJB2 mutations [30]. 
In another study on 75 Iranian families segregating 
ARNSHL, 1 family (1.33%) was linked to DFNB21 
[31]  and finally, in a genetic linkage study of fourty 
ARNSHL families living in Markazi and Qom provin-
ces of Iran with at least 3 affected individuals per fa-
mily, no instance of linkage to DFNB21 was found [35]. 
We were unable to find any linked family to 
DFNB59. The locus, mapped to at 2q31.2, and the 
corresponding gene, PJVK, has recently been identified 
in 4 Iranian families [32]. The protein was named 
pejvakin, derived from a Persian word meaning echo. 
Screening of 67 Turkish ARNSHL families led to 
finding of a linked family. It was concluded that it was 
not playing a significant role in the pathogenesis of HL 
in the Turkish patients [33]. In a study on 30 Iranian 
ARNSHL families, 2 families  (6.7%) were found to be 
linked. The investigators proposed checking the locus in 
the Iranian ARNSHL families [34]. In a recent study 
carried out by PCR-RFLP for two exons of PJVK, on 
100 ARNSHL individuals from Shahrekord city, 
Chaharmahal va Bakhtiari provinve of Iran, no mutation 
was found. Since the study was not at all 
comprehensive, the possibility of DFNB59 involvement 
could not be ruled out [35]. Based on our study, It is 
possible that DFNB59 plays no major role in the 
pathogenesis of ARNSHL. 
In the present study, after excluding the GJB2 and 
GJB6 causes, linkage analysis was performed for 5 
DFNB loci including DFNB3, DFNB4, DFNB7/11, 
DFNB21 and DFNB59. Totally, the causes of 30.5 % of 
the studied ARNSHL families were clarified which is of 
importance given the lower prevalence of GJB2 in the 
Iranian ARNSHL families as well as the extreme 
heterogeneity of the disease, with the engagement of 
over 70 loci. Other genetic and epigenetic factors should 
be investigated to clarify the etiology of the remaining 
families. The next phase of the study involves screening 
for other known loci and the genome scan analysis of 
the remaining families with high statistical power 
(SLINK≥ 3.3). The  design and practice of similar 
studies on the different populations of Iran will provide 
a wealth of population-specific knowledge for genetic 
diagnosis and genetic counseling of the families. 
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